
Metoprolol Succinate (47.5mg)
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Metvolen XL 50 Tablet is a once-daily extended-release formulation of Metoprolol Succinate, a beta1-selective adrenoceptor blocker indicated for the treatment of hypertension, angina pectoris, and stable left ventricular dysfunction. This tablet is designed to provide a sustained therapeutic effect over a 24-hour period, allowing for a single daily dose to control blood pressure and alleviate symptoms of angina. Metoprolol Succinate, the active ingredient, is a prodrug that is converted to its active form, metoprolol, in the gastrointestinal tract. The extended-release formulation of Metoprolol Succinate is designed to provide a consistent and predictable release of metoprolol over an extended period, thereby minimizing the variability in peak concentrations and duration of action. As a beta-blocker, Metvolen XL 50 Tablet exerts its therapeutic effects by reducing cardiac output, peripheral resistance, and heart rate, while also reducing the release of renin and aldosterone, leading to a decrease in blood pressure.
Alcohol & phenols
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metvolen XL 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metvolen XL 50 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Metvolen XL 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Metvolen XL 50 Tablet is recommended.
Exercise Caution
Metvolen XL 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Metvolen XL 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Metvolen XL 50 Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Metvolen XL 50 Tablet

Metoprolol Succinate (47.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Metvolen XL 50 Tablet is a once-daily extended-release formulation of Metoprolol Succinate, a beta1-selective adrenoceptor blocker indicated for the treatment of hypertension, angina pectoris, and stable left ventricular dysfunction. This tablet is designed to provide a sustained therapeutic effect over a 24-hour period, allowing for a single daily dose to control blood pressure and alleviate symptoms of angina. Metoprolol Succinate, the active ingredient, is a prodrug that is converted to its active form, metoprolol, in the gastrointestinal tract. The extended-release formulation of Metoprolol Succinate is designed to provide a consistent and predictable release of metoprolol over an extended period, thereby minimizing the variability in peak concentrations and duration of action. As a beta-blocker, Metvolen XL 50 Tablet exerts its therapeutic effects by reducing cardiac output, peripheral resistance, and heart rate, while also reducing the release of renin and aldosterone, leading to a decrease in blood pressure.
Alcohol & phenols
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metvolen XL 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metvolen XL 50 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Metvolen XL 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Metvolen XL 50 Tablet is recommended.
Exercise Caution
Metvolen XL 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Metvolen XL 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Metvolen XL 50 Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Metvolen XL 50 Tablet















